acute myeloid leukemia

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Print

Disease Overview

Acute myeloid leukemia (AML) is a group of neoplasms arising from precursor cells committed to the myeloid cell-line differentiation. All of them are characterized by clonal expansion of myeloid blasts. AML manifests by fever, pallor, anemia, hemorrhages and recurrent infections.


Synonyms

  • AML
  • AML - acute myeloid leukaemia
  • AML - acute myeloid leukemia
  • ANLL
  • acute Nonlymphocytic leukaemia
  • acute Nonlymphocytic leukemia
  • acute granulocytic leukaemia
  • acute granulocytic leukemia
  • acute myeloblastic leukaemia
  • acute myeloblastic leukemia
  • acute myelocytic leukaemia
  • acute myelocytic leukemia
  • acute myelogenous leukaemia
  • acute myelogenous leukemia
  • acute myelogenous leukemias
  • acute myeloid leukaemia (AML)
  • acute myeloid leukemia
  • acute myeloid leukemia (AML)
  • acute myeloid leukemia, somatic
  • acute non lymphoblastic leukaemia
  • acute non lymphoblastic leukemia
  • acute nonlymphocytic leukaemia
  • acute nonlymphocytic leukemia
  • hematopoeitic - acute Myleogenous leukaemia (AML)
  • hematopoeitic - acute Myleogenous leukemia (AML)
  • leukemia, acute myelogenous
  • leukemia, acute myeloid
  • leukemia, acute myeloid, autosomal dominant, somatic mutation
  • leukemia, acute myeloid, reduced survival in, somatic
  • leukemia, acute myeloid, somatic
  • leukemia, acute myeloid, susceptibility to
  • leukemia, acute myeloid, susceptibility to, autosomal dominant, somatic mutation
  • leukemia, myelocytic, acute
  • myeloid leukemia, acute
  • myeloid leukemia, acute, M4/M4Eo subtype, somatic

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report
OMIM

Online Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.

View report
National Organization for Rare Disorders